Immune & Inflammatory5 mgLL-37
Human Cathelicidin Peptide
The human antimicrobial peptide at the frontline of innate immunity.
About this peptide
LL-37 is the body's own broad-spectrum antimicrobial peptide — the frontline of innate immunity against bacteria, viruses and fungi, and a powerful driver of wound healing.
LL-37 destroys pathogens by disrupting their membranes and simultaneously coordinates the immune response, recruiting the right cells to the right places. It also accelerates wound closure, angiogenesis and re-epithelialisation.
Users experience stronger resistance to chronic and biofilm infections, faster wound and skin healing, and a healthier immune baseline. It is a keystone peptide for anyone with recurrent or resistant infections.
Key highlights
Active against bacteria, viruses, fungi and biofilms.
Recruits and directs immune cells to sites of infection.
Accelerates closure and re-epithelialisation.
Strengthens the body's first line of protection.
Research applications
- Powerful broad-spectrum antimicrobial activity
- Fights chronic and biofilm infections
- Accelerates wound and skin healing
- Strengthens innate immune defence
- Modulates inflammation intelligently
- Supports resilience against recurrent infections
Specifications
- Sequence
- 37 amino acids
- Presentation
- 5 mg lyophilised vial
- Analytical
- Batch tested · HPLC verified
- Storage
- 2–8 °C, protect from light
For research use only. Not intended for human or veterinary therapeutic use.
